SELMA ALIN SOMILLEDA-VENTURA

Dr. SELMA ALIN SOMILLEDA-VENTURA

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Optometry
Verified
Journal Article
Open access
SSSELMA ALIN SOMILLEDA-VENTURA
SELMA ALIN SOMILLEDA-VENTURA
GCGuillermo Ceballos
Guillermo Ceballos
VLVirgilio Lima-Gómez
Virgilio Lima-Gómez
To compare the retinal sensitivity and evaluate its contribution to the foveal sensitivity in patients with and without diabetes who maintain normal visual acuity. Observational, descriptive, cross-sectional and prospective study in 20 subjects without diabetes (group 1) and 23 with type 2 diabetes mellitus (group 2) that had no ocular abnormalities. Retinal sensitivity was measured with the macular threshold test by the Humphrey's computerized perimeter. The mean sensitivity in each of the 16 points and the foveal sensitivity were compared between groups using the Mann-Whitney's U test; the correlation between retinal sensitivity and foveal sensitivity was analyzed by the Spearman's test and the contribution of each point to the foveal sensitivity was identified by multiple regression. Sixty eyes were evaluated, 30 in group 1 and 30 in group 2; the mean foveal sensitivity was 34.77±0.5dB in group 1 and 32.87±0.6 in group 2. The highest sensitivity of the temporal visual field had an inferior paracentral location (point 3) in both groups. In the linear regression analysis, points which contributed to the foveal sensitivity were 1 in group 1 and points 7 and 15 in group 2. Subjects without diabetes have a significantly higher sensitivity in the temporal retina compared with those with diabetes; points with highest mean retinal sensitivity do not correspond to the central four. The reduced sensitivity in point 1 decreases the mean foveal sensitivity in subjects with diabetes, because this variable correlates with lower perimetry points.

26 June 2019 in Cirugía y Cirujanos
Verified
Journal Article
Closed access
SSSELMA ALIN SOMILLEDA-VENTURA
SELMA ALIN SOMILLEDA-VENTURA
DRDulce M Razo-Blanco-Hernández
Dulce M Razo-Blanco-Hernández
JRJesús A Reyes-Calderón
Jesús A Reyes-Calderón
GCGuillermo Ceballos
Guillermo Ceballos
VLVirgilio Lima-Gómez
Virgilio Lima-Gómez
To characterize the distribution of the foveal avascular zone circularity and its correlation with parafoveal vessel density, in subjects with and without diabetes. Observational, descriptive, cross-sectional, and prospective study; subjects without diabetes (Group 1), with diabetes without retinopathy (Group 2), or with diabetic retinopathy (Group 3) were included. Means of foveal avascular zone circularity and parafoveal vessel density were compared between groups (Kruskal-Wallis) and their correlation was calculated with Spearman's Rho test. Seventy-seven eyes; central vessel density mean was higher in Group 1 than in Group 2 and higher in Group 2 than in Group 3; inner and complete vessel density means were also higher in Group 2 than in Group 3. The mean of the foveal avascular zone circularity did not differ between groups, and in Group 3 it had a positive correlation with central (0.45), inner (0.56), and complete (0.53) vessel densities. Circularity does not differ between subjects with diabetes, with and without retinopathy, and has only a low correlation with parafoveal vessel density in people with diabetic retinopathy, which does not allow anticipating a reduction of vessel density in this disease.

25 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IMIlse Sarahí Márquez-Vergara
Ilse Sarahí Márquez-Vergara
GRGeovanni Jassiel Ríos-Nequis
Geovanni Jassiel Ríos-Nequis
IPIngrid Yazmín Pita-Ortíz
Ingrid Yazmín Pita-Ortíz
HPHéctor Javier Pérez-Cano
Héctor Javier Pérez-Cano
SSSELMA ALIN SOMILLEDA-VENTURA
SELMA ALIN SOMILLEDA-VENTURA
Visual-related quality of life in retinal diseases has not been explored in the Mexican population, so the study aims to identify it in patients undergoing surgery due to advanced diabetic retinopathy, rhegmatogenous retinal detachment, and other causes of vitrectomy; the Visual Function Quality-25 questionnaire was applied to 76 patients, pre-and postoperative. It was divided into 10 domains and interpreted according to the National Eye Institute scores, where the highest value was the best visual function. Student's t-test for related samples and Wilcoxon’s t-test were used to compare each domain between measurements, and Pearson’s R test to correlate the total score of age and quality of life; a p value < 0.05 was considered significant. Diabetic retinopathy patients showed an improvement 1 and 3 months after surgery in all domains; in rhegmatogenous retinal detachment, there was an improvement observed up to 3 months, while a decrease in ocular pain was observed in other causes of vitrectomy. Differences found in all the quality-of-life scores were not statistical, but clinically significant. The study shows that visual-related quality of life domains improves after vitrectomy; the inclusion of this analysis might be considered relevant within the parameters of surgical success of the most prevalent vitreoretinal diseases.

26 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSSELMA ALIN SOMILLEDA-VENTURA
SELMA ALIN SOMILLEDA-VENTURA
DBDulce Milagros Razo Blanco-Hernández
Dulce Milagros Razo Blanco-Hernández
SSSurisadai Serafín-Solís
Surisadai Serafín-Solís
VLVirgilio Lima-Gómez
Virgilio Lima-Gómez
Photocoagulation may still be a therapeutic choice for center-sparing diabetic macular edema. We compared the visual evolution after photocoagulation, in eyes with focal diabetic macular edema, stratified per the location of thickening with optical coherence tomography. We evaluated people with type 2 diabetes and focal diabetic macular edema, before and three weeks after focal photocoagulation. We divided the sample by edema location: central (group1); paracentral (group 2) and pericentral (group 3) and compared the proportions of eyes with baseline visual impairment, visual improvement, and visual deterioration between groups; central edema was evaluated with logistic regression, as an explaining variable of baseline visual impairment and visual improvement. The study included 160 eyes: 77 in group 1, 20 in group 2, 63 in group 3; baseline visual impairment was more frequent in groups 1 and 2 (52.6%) than in group 3 (28.6%, p = 0.002, OR 2.77) and as common in groups 1 (51.9%) and 2 (55.0%, p = 0.8). The proportions of visual improvement and visual deterioration did not differ between groups (p > 0.05). The outcome after focal photocoagulation was similar in paracentral (considered center-sparing) and central macular edema; the definition of center involvement, which needs intravitreal antiangiogenics, should expand to include paracentral thickening.

1 October 2018 in Gaceta Médica de México
Verified
Journal Article
Closed access
VLVirgilio Lima-Gómez
Virgilio Lima-Gómez
DBDulce Milagros Razo Blanco-Hernández
Dulce Milagros Razo Blanco-Hernández
SSSELMA ALIN SOMILLEDA-VENTURA
SELMA ALIN SOMILLEDA-VENTURA
Parafoveal capillary density changes have not been characterized in type 2 diabetics without retinopathy. To compare parafoveal capillary density between healthy subjects, and diabetics with and without retinopathy. Observational, prospective, transversal and comparative study; subjects without diabetes (group 1), diabetics without retinopathy (group 2), with retinopathy (group 3) and with diabetic macular edema (group 4), without macular ischemia, were included. The study variable was parafoveal capillary density, and the predictor variables were the measures of the foveal avascular zone, retinal thickness and the group. The variables were compared between groups using Kruskal-Wallis and Spearman's Rho tests. One hundred and forty eyes were evaluated; parafoveal capillary density was higher in group 1 than in the rest (p < 0.05). Area, perimeter and diameter of the foveal avascular zone were higher in group 3. A positive correlation existed a positive between parafoveal capillary density and central field thickness in groups 1, 2 and 3. Parafoveal capillary density decreases as diabetes-induced damage increase; a reduction may exist in diabetics without retinopathy and normal retinal thickness and foveal avascular zone are normal. The clinical impact of this finding requires further evaluation.

9 September 2024 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
OMOscar Morales-Lopez
Oscar Morales-Lopez
OROctavio Rodríguez-Cortés
Octavio Rodríguez-Cortés
PLPedro López-Sánchez
Pedro López-Sánchez
HPHéctor Javier Pérez-Cano
Héctor Javier Pérez-Cano
OGOmar García-Liévanos
Omar García-Liévanos
SSSELMA ALIN SOMILLEDA-VENTURA
SELMA ALIN SOMILLEDA-VENTURA
Antidiabetic therapies are effective, but could indirectly modify the inflammatory response in the ocular microenvironment; therefore, a study was developed to evaluate the inflammatory cytokine profile in the vitreous humor of diabetic patients with retinopathy under treatment with antidiabetic drugs. Observational, comparative, retrospective, cross-sectional study. Interleukins 1β, 6, 8, 10, and tumor necrosis factor-alpha (TNFα) were evaluated in the vitreous humor obtained from patients with type 2 diabetes mellitus, proliferative diabetic retinopathy, and concomitant retinal detachment or vitreous hemorrhage, and who were already on antidiabetic treatment with insulin or metformin + glibenclamide. The quantification analysis of each cytokine was performed by the cytometric bead array (CBA) technique; medians and interquartile ranges were obtained, and the results were compared between groups using the Mann-Whitney U test, where a p-value < 0.05 was considered significant. Thirty-eight samples; quantification of TNFα concentrations was higher in the group of patients administered insulin, while interleukin-8 was lower; in the metformin + glibenclamide combination therapy group, it occurred inversely. In the stratified analysis, the highest concentrations of interleukin-8 and TNFα occurred in patients with vitreous hemorrhage; however, the only statistical difference existed in patients with retinal detachment, whose TNFα concentration in the combined therapy group was the lowest value found (53.50 (33.03–86.66), p = 0.03). Interleukins 1β, 6, and 10 were not detected. Interleukin-8 and TNFα concentrations are opposite between treatment groups; this change is more accentuated in patients with proliferative diabetic retinopathy and vitreous hemorrhage, where the highest concentrations of both cytokines are found, although only TNFα have statistical difference.